GE HealthCare stock gains as Needham sets a USD 93 target
Published on 09/22/2026 at 20:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare Technologies Inc. (US36266G1076) traded at USD 64.81 on Nasdaq on September 22, 2026, up 1.06 percent from the prior close. The move followed Needham's initiation of coverage with a Buy rating and a USD 93 price target, as CNBC reported on September 22, 2026.
Needham sees valuation upside
Needham's USD 93 target stands USD 28.19 above the September 22, 2026 quote, implying 43.5 percent upside from the September 21 close of USD 64.81. The target is also materially above the stock's 52-week high of USD 89.77, so the call depends on a renewed valuation premium rather than a simple return to the recent trading range.
The valuation argument is specific. TradingView reported on September 22, 2026 that GE HealthCare traded at a 2026 price-to-earnings multiple of 13.2 times, compared with a large-cap peer median of 18.8 times. That 5.6-point discount is the central quantified reason for the bullish view.
Second-quarter figures set the base
GE HealthCare generated USD 5.295 billion in revenue in the second quarter of 2026, with organic revenue growth of 3.5 percent year over year. Adjusted earnings per share reached USD 1.13, above Oppenheimer's USD 1.05 estimate and the USD 1.04 consensus cited by Investing.com on September 22, 2026.
Order momentum was stronger than revenue growth: organic orders increased 11.1 percent in the second quarter of 2026, according to the same reported company results. The gap between 11.1 percent order growth and 3.5 percent organic revenue growth makes conversion of the order pipeline the key operating test behind the higher valuation case.
Stock remains below its yearly high
The Nasdaq quote stood between the September 22, 2026 intraday low of USD 63.71 and high of USD 65.10. The 52-week range was USD 58.75 to USD 89.77, while the market capitalization was USD 29.27 billion and volume was 3,471,034 shares, according to the dated quote data reported by Yahoo Finance.
The stock's 2026 performance remained negative at minus 20.98 percent on September 22, 2026. That decline contrasts with the latest operating comparison: adjusted EPS of USD 1.13 exceeded the USD 1.04 consensus by USD 0.09 in the second quarter of 2026, giving the market a concrete earnings counterpoint to the weak year-to-date share performance.
GE HealthCare stock closes at USD 64.81
GE HealthCare stock was quoted at USD 64.81 on Nasdaq on September 22, 2026, with a daily gain of 1.06 percent. The USD 93 Needham target and the USD 29.27 billion market capitalization frame the current debate around earnings delivery, order conversion and valuation.
GE HealthCare stock data
- Company: GE HealthCare Technologies Inc.
- ISIN: US36266G1076
- Ticker: GEHC
- Trading venue: Nasdaq
- Price (as of September 22, 2026): USD 64.81
- Market capitalization: USD 29.27 billion (as of September 22, 2026)
- Sector / Industry: Health Care / Health Care Equipment and Supplies
